Mission Bay Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
2
- Investments
-
73
- Portfolio
-
23
- Exits
-
26
Mission Bay Capital General Information
Company Description
Founded in 2009, Mission Bay Capital is a venture capital firm based in San Francisco, California. The firm seeks to invest in early-stage bioscience companies.
Business Details
Website
www.missionbaycapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 953 Indiana Street
- San Francisco, CA 94107
- United States
Mission Bay Capital Investments (73)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Interdict Bio | 10-Sep-2025 | Early Stage VC | Biotechnology | Pre-Clinical Trials | ||
| Alessa Therapeutics | 18-Apr-2025 | Drug Delivery | Clinical Trials - Phase 1 | |||
| QurAlis | 09-Mar-2023 | Therapeutic Devices | Clinical Trials - Phase 1 | |||
| Symbiome | 30-Jun-2022 | Personal Products | Generating Revenue | |||
| Ambagon Therapeutics | 05-Jan-2022 | Drug Discovery | Clinical Trials - General | |||
| Nitrase Therapeutics | 02-Nov-2021 | Drug Discovery | Generating Revenue | |||
| Sound Agriculture | 19-Aug-2021 | Agricultural Chemicals | Generating Revenue | |||
| Alpine Bio | 22-Jul-2021 | Food Products | Generating Revenue | |||
| Telo Therapeutics | 21-Jun-2021 | Seed Round | Drug Discovery | Generating Revenue | ||
| Glycomine | 11-Jun-2021 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 |
Mission Bay Capital Exits (26)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Avvio Medical | 01-Jan-2026 | Secondary Transaction - Private | |
| Photoswitch Biosciences | 23-Aug-2025 | ||
| SiteOne Therapeutics | 28-Jul-2025 | ||
| Bolt Projects Holdings | 13-Aug-2024 | ||
| Mitokinin | 04-Oct-2023 | ||
| Fluxion (Diagnostic Equipment) | 23-Aug-2023 | ||
| ViewPoint Therapeutics | 28-Jul-2022 | ||
| Magnamosis | 27-Sep-2021 | ||
| Effector Therapeutics | 25-Aug-2021 | Reverse Merger | |
| Caribou Biosciences | 23-Jul-2021 | IPO |
Mission Bay Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Mission Bay Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Mission Bay Capital Co-Investors (28)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Mission BioCapital | 3 |
|
|
||
| Droia Ventures |
|
|
|||
| Inkef |
|
|
|||
| Amgen Ventures |
|
|
|||
| Citadel Enterprise Americas |
|
|
Mission Bay Capital FAQs
-
What is Mission Bay Capital?
Founded in 2009, Mission Bay Capital is a venture capital firm based in San Francisco, California.
-
When was Mission Bay Capital founded?
Mission Bay Capital was founded in 2009.
-
Where is Mission Bay Capital headquartered?
Mission Bay Capital is headquartered in San Francisco, CA.
-
What is Mission Bay Capital's total asset value?
Mission Bay Capital has around in total assets under management.
-
How many investments has Mission Bay Capital made?
Mission Bay Capital has made 73 investments.
-
What has Mission Bay Capital invested in?
Mission Bay Capital has made numerous investments in companies like Interdict Bio, Alessa Therapeutics, and QurAlis within the Biotechnology, Drug Delivery, and Therapeutic Devices industries.
-
What has Mission Bay Capital invested in recently?
Mission Bay Capital's latest investment was on 10-Sep-2025 in Interdict Bio, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
